Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2015 ACR/ARHP Annual Meeting: Next Generation Sequencing and Disease Mechanisms

Mary Beth Nierengarten  |  Issue: February 2016  |  February 17, 2016

In addition, she said that somatic mutations can be missed with WES and evidence increasingly shows the importance of these mutations for pathogenesis of disease, particularly late-onset disease.

Finally, she emphasized the need for collaboration to narrow down the list of candidate genes. “It is very important to work together when it comes to patients with rare inflammatory disease,” she said. “We should share data from our patients and collaborate in pursing new gene discoveries.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Lung Involvement

As one example of collaboration in looking for rare variants associated with rheumatic diseases, Tony Shum, MD, assistant professor, Pulmonary & Critical Care, Cardiovascular Research Institute, University of California San Francisco, spoke on work underway to better understand the role of the lung in systemic autoimmunity.

Dr. Shum

Dr. Shum

He spoke on research in which he and his colleagues used WES to map rare variants in families with autoimmune arthritis with a dominant lung phenotype. They found that a rare variant, coatomer subunit alpha (COPA), was ubiquitously expressed in these patients. As a subunit of coat protein complex I (COPI), COPA enables protein transport between the Golgi and endoplasmic reticulum.3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Further research showed that mutations in the WD40 COPA domain cause autoimmune-associated lung and joint disease and identified a novel vesicular trafficking defect as the cause of autoimmunity. Their research also identified a novel molecular link between ER stress and the generation of immunity.

Prior to this research, no diseases were associated with COPA or COPI. As such, Dr. Shum said that this research points to the discovery and definition of a new syndrome, called the COPA syndrome, in which patients have pulmonary hemorrhage, interstitial lung disease and arthritis with or without autoantibodies.

Given the link between endoplasmic reticulum stress with both lung disease and the generation of immunity, further research is underway focusing on trying to understand the role of endoplasmic reticulum stress in the lung epithelium and how it may be involved more broadly in systemic autoimmunity.4,5

Dr. Shum said that this research supports emerging evidence on the importance of the lung “not only as a disease manifestation of autoimmunity but really as the tissue site in which autoimmunity might be proliferated or propagated.”6

“I think the way for clinicians to think about this is [as confirmation] of the need to tell their patients that they should not smoke, the rationale being that the lung may play a role in precipitating overall disease,” he said.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsResearch RheumTechnology Tagged with:2015 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)geneticnext generation sequencingpathwaysResearchvariant

Related Articles

    Exploring the Complement System in Human Disease

    February 1, 2010

    Novel disease associations revealed by whole genome screens

    Translating Genetic Discoveries into Rheumatic Therapies

    March 18, 2018

    SAN DIEGO—Will rheumatologists soon be able to use data from genetics and genome-wide association studies to more accurately predict disease and develop new therapies for rheumatic diseases? At a Nov. 5 session at the 2017 ACR/ARHP Annual Meeting, experts shared their views on how to glean this useful knowledge from genomics studies. The cost to develop…

    Shortcomings and Promises of Genome-wide Association Studies

    February 3, 2012

    The outcomes of genome-wide association studies (GWAS) have not been what scientists expected, but researchers are developing new approaches to use revelatory GWAS information to identify genetic causal variants, predictors of treatment response, and future opportunities for genetic insight.

    Experts Discuss the Latest Precision Medicine Research

    February 18, 2018

    SAN DIEGO—In just two decades, precision medicine has gone from futuristic concept to realistic toolbox for clinical physicians. At the 2017 ACR Clinical Research Conference on Nov. 3, the Precision Medicine in Rheumatic Diseases: Hopes and Challenges lecture featured rheumatologists and experts on genetics, genomics, pharmaco­genetics and big data who spoke about the latest research…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences